polyurethane foam

12/01/2016 - "To demonstrate the efficacy of a highly hydrophilic polyurethane foam dressing in the treatment of diabetic ulcers. "
12/01/2020 - "The aim of the study was to compare the efficacy of PD, PAHA and polyurethane foam in chronic ulcers. "
12/01/2016 - "Polyurethane foam dressings have been used worldwide to accelerate wound healing, but only a few clinical studies demonstrate the effect of foam dressing on the healing of diabetic ulcers. "
12/01/2020 - "PD and PAHA proved to be more effective than polyurethane foam in the treatment of chronic ulcers. "
05/01/2020 - "The aim of this study was to evaluate the efficacy of a novel local therapy based on polyurethane foam dressings, namely the Highly Hydrophilic Polyurethane Foam (HPF), in addition to the conventional pharmacological treatment, in a cohort of 41 SSc patients with at least one active ulcer. "

07/01/2014 - "We previously reported that a self-expanding polyurethane foam significantly improved survival in a lethal hepatoportal injury model of massive venous hemorrhage. "
02/01/2015 - "Efficacy of a prehospital self-expanding polyurethane foam for noncompressible hemorrhage under extreme operational conditions."
02/01/2009 - "Prospective, double-blind, randomized trial evaluating patient satisfaction, bleeding, and wound healing using biodegradable synthetic polyurethane foam (NasoPore) as a middle meatal spacer in functional endoscopic sinus surgery."
07/01/2015 - "Our team previously described a self-expanding polyurethane foam for the treatment of exsanguinating abdominal hemorrhage. "
04/01/2015 - "[First experience of a polyurethane foam composition "Locus" use to stop intra-abdominal hemorrhage as a result of liver damage of V degree. "

11/01/2019 - "This study quantitatively compared four polyurethane foam-based wound dressings for their absorption profile, cell penetration, and adherence using two novel in vitro assays. "
11/01/2015 - "Polyurethane foam containing rhEGF as a dressing material for healing diabetic wounds: Synthesis, characterization, in vitro and in vivo studies."
09/01/2009 - "PermaFoam, the dressing under study, is characterized as a polyurethane foam having gradient pores which, besides all the aforementioned characteristics, makes it possible to: rapidly absorb large quantity of seepage or exudation, cell remains and viscous seepage thanks to a layer of large size pores that are in contact with the wound; distribute and retain seepage in an intermediate layer of this dressing which is composed of pores having a smaller diameter; and, through a final layer characterized by an even smaller pore which permits a high degree of semi-permeability and adaptability to the distinct locales where this dressing needs be applied. "
03/01/2009 - "In the present study, the early effects of NPWT on pressure transduction and wound contraction were examined in wounds filled with either polyurethane foam or gauze. "
06/01/1994 - "A prospective non-controlled correlational study was undertaken with ten patients and twelve wounds using a polyurethane foam dressing to reduce hypergranulation tissue. "

04/01/2023 - "For both patients, the additional application of polyurethane foam was effective for preventing pressure injuries. "
04/01/2023 - "These case reports support the addition of polyurethane foam to prevent pressure injuries in patients placed in the prone position."
10/01/2022 - "Predicting the cut-off point for interface pressure in pressure injury according to the standard hospital mattress and polyurethane foam mattress as support surfaces."
11/01/2020 - "Effectiveness of Multilayered Polyurethane Foam Dressings to Prevent Hospital-Acquired Sacral Pressure Injuries in Patients With Hip Fracture: A Randomized Controlled Trial."
09/24/2020 - "The prevalence of pressure ulcers in the European Union (EU) is believed to be 13.7%. Recent guidelines have recommended the consideration of polyurethane foam dressings as part of pressure injury prevention strategies. "

11/01/2012 - "The lowering of capsular contracture rates noted with the past use of polyurethane foam-covered implants has increased awareness of the importance of the biologic response at the interface between the implant surface and breast tissue. "
05/01/2006 - "The incidence of capsular contracture was dramatically lower with polyurethane foam-covered implants compared to smooth or mechanically textured implants; this beneficial effect persisted at least 10 years after implantation. "
10/01/1990 - "Polyurethane foam-covered implants and capsular contracture: a laboratory investigation."
03/01/2006 - "The longer implants were in place, the greater the cumulative risk of developing contracture; hematoma significantly increased the risk of contracture; smooth and textured implants had similar contracture rates; polyurethane foam-covered implants had a reduced risk of contracture persisting for at least 10 years after implantation. "
01/01/2015 - "Polyurethane foam covered breast implants remain a valid choice for the treatment of capsular contracture even if it would be very useful to verify the ease of removal of the prosthesis and to continue investigations on biodegradation products."